Search Page

1

Cite

Share

Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.

Liubomirski Y, Lerrer S, Meshel T, Rubinstein-Achiasaf L, Morein D, Wiemann S, Körner C, Ben-Baruch A. Liubomirski Y, et al. Among authors: meshel t. Front Immunol. 2019 Apr 12;10:757. doi: 10.3389/fimmu.2019.00757. eCollection 2019. Front Immunol. 2019. PMID: 31031757 Free PMC article.

Cite

Share

2

Cite

Share

Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.

Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, Wiemann S, Körner C, Ehrlich M, Ben-Baruch A. Liubomirski Y, et al. Among authors: meshel t. Front Immunol. 2019 Apr 24;10:804. doi: 10.3389/fimmu.2019.00804. eCollection 2019. Front Immunol. 2019. PMID: 31105691 Free PMC article.

Cite

Share

3

Cite

Share

Inter-Tumor Heterogeneity-Melanomas Respond Differently to GM-CSF-Mediated Activation.

Moshe A, Izraely S, Sagi-Assif O, Malka S, Ben-Menachem S, Meshel T, Pasmanik-Chor M, Hoon DSB, Witz IP. Moshe A, et al. Among authors: meshel t. Cells. 2020 Jul 13;9(7):1683. doi: 10.3390/cells9071683. Cells. 2020. PMID: 32668704 Free PMC article.

Cite

Share

4

Cite

Share

Regeneration Enhances Metastasis: A Novel Role for Neurovascular Signaling in Promoting Melanoma Brain Metastasis.

Prakash R, Izraely S, Thareja NS, Lee RH, Rappaport M, Kawaguchi R, Sagi-Assif O, Ben-Menachem S, Meshel T, Machnicki M, Ohe S, Hoon DS, Coppola G, Witz IP, Carmichael ST. Prakash R, et al. Among authors: meshel t. Front Neurosci. 2019 Apr 9;13:297. doi: 10.3389/fnins.2019.00297. eCollection 2019. Front Neurosci. 2019. PMID: 31024232 Free PMC article.

Cite

Share

5

Cite

Share

The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.

Izraely S, Ben-Menachem S, Sagi-Assif O, Meshel T, Malka S, Telerman A, Bustos MA, Ramos RI, Pasmanik-Chor M, Hoon DSB, Witz IP. Izraely S, et al. Among authors: meshel t. Mol Oncol. 2020 Dec 3. doi: 10.1002/1878-0261.12872. Online ahead of print. Mol Oncol. 2020. PMID: 33274599 Free article.

Cite

Share

6

Cite

Share

The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts.

Neuditschko B, Janker L, Niederstaetter L, Brunmair J, Krivanek K, Izraely S, Sagi-Assif O, Meshel T, Keppler BK, Del Favero G, Witz IP, Gerner C. Neuditschko B, et al. Among authors: meshel t. Mol Cell Proteomics. 2020 Mar;19(3):478-489. doi: 10.1074/mcp.RA119.001886. Epub 2019 Dec 31. Mol Cell Proteomics. 2020. PMID: 31892524 Free PMC article.

Cite

Share

7

Cite

Share

CCR4 is a determinant of melanoma brain metastasis.

Klein A, Sagi-Assif O, Meshel T, Telerman A, Izraely S, Ben-Menachem S, Bayry J, Marzese DM, Ohe S, Hoon DSB, Erez N, Witz IP. Klein A, et al. Among authors: meshel t. Oncotarget. 2017 May 9;8(19):31079-31091. doi: 10.18632/oncotarget.16076. Oncotarget. 2017. PMID: 28415693 Free PMC article.

Cite

Share

8

Cite

Share

PHOX2B is a suppressor of neuroblastoma metastasis.

Naftali O, Maman S, Meshel T, Sagi-Assif O, Ginat R, Witz IP. Naftali O, et al. Among authors: meshel t. Oncotarget. 2016 Mar 1;7(9):10627-37. doi: 10.18632/oncotarget.7056. Oncotarget. 2016. PMID: 26840262 Free PMC article.

Cite

Share

9

Cite

Share

Hexokinase 2 is a determinant of neuroblastoma metastasis.

Botzer LE, Maman S, Sagi-Assif O, Meshel T, Nevo I, Yron I, Witz IP. Botzer LE, et al. Among authors: meshel t. Br J Cancer. 2016 Mar 29;114(7):759-66. doi: 10.1038/bjc.2016.26. Epub 2016 Mar 17. Br J Cancer. 2016. PMID: 26986252 Free PMC article.

Cite

Share

10

Cite

Share

The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.

Izraely S, Ben-Menachem S, Sagi-Assif O, Telerman A, Zubrilov I, Ashkenazi O, Meshel T, Maman S, Orozco JIJ, Salomon MP, Marzese DM, Pasmanik-Chor M, Pikarski E, Ehrlich M, Hoon DSB, Witz IP. Izraely S, et al. Among authors: meshel t. Int J Cancer. 2019 Feb 15;144(4):802-817. doi: 10.1002/ijc.31745. Epub 2018 Nov 1. Int J Cancer. 2019. PMID: 29992556 Free article.

Cite

Share